|
|
China Aoxing Granted Approval for OTC Pain Drug
publication date: Dec 11, 2008
China Aoxing Pharmaceutical Company was awarded an SFDA production license for Paracetamol (acetaminophen) and Caffeine Tablets, a treatment for mild to moderate pain. Although the new product will be marketed as an OTC drug, it is considered a controlled substance by the SFDA. China Aoxing is one of a relatively few companies that is licensed to manufacture narcotic and controlled substance pain medication drugs in China. China Aoxing said the company will launch the product in early 2009, once it receives GMP certification. More details... Stock Symbol: (OTCBB: CAXG)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|